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Caspase-2 is unique among all the mammalian cas-
pases in that it is the only caspase that is present
constitutively in the cell nucleus, in addition to other
cellular compartments. However, the functional
significance of this nuclear localization is unknown.
Here we show that DNA damage induced by g-radia-
tion triggers the phosphorylation of nuclear caspase-2
at the S122 site within its prodomain, leading to its
cleavage and activation. This phosphorylation is
carried out by the nuclear serine/threonine protein
kinase DNA-PKcs and promoted by the p53-
inducible death-domain-containing protein PIDD
within a large nuclear protein complex consisting of
DNA-PKcs, PIDD, and caspase-2, which we have
named the DNA-PKcs-PIDDosome. This phosphory-
lation and the catalytic activity of caspase-2 are
involved in the maintenance of a G2/M DNA damage
checkpoint and DNA repair mediated by the nonho-
mologous end-joining (NHEJ) pathway. The DNA-
PKcs-PIDDosome thus represents a protein complex
that impacts mammalian G2/M DNA damage check-
point and NHEJ.
INTRODUCTION
Apoptosis in mammalian cells is executed mainly by the effector
caspase-3 and caspase-7, which are activated through cleavage
mediated by the initiator caspase-9 or caspase-8/10 (Degterev
et al., 2003). Caspase-9 is activated by the Apaf-1 apoptosome
in the cytoplasm, whose formation is triggered by the release of
mitochondrial cytochrome c from mitochondria to cytosol (Li
et al., 1997; Wang, 2001). Caspase-8/10 is activated by the
death-inducing signaling complex (DISC) at the cytoplasmic
side of the cell membrane formed upon ligation of apoptosis-
inducing receptor ligands to their corresponding cell membrane
receptors (Peter and Krammer, 2003). In addition to these well-
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mans and caspase-1, 11, and 12 in mice function in the process-
ing of proinflammatory cytokines (Martinon and Tschopp, 2007).
Caspase-2 was the second caspase cloned (Kumar et al.,
1994; Wang et al., 1994). Despite many reports regarding the
function of caspase-2 in a variety of apoptotic processes (Troy
and Shelanski, 2003; Zhivotovsky and Orrenius, 2005), the
precise role of caspase-2 in apoptosis remains to be verified
in vivo because caspase-2-knockout mice display few apoptotic
defects (Bergeron et al., 1998; O’Reilly et al., 2002).
Caspase-2 is known to be cleaved and activated by a cytosolic
protein complex termed the PIDDosome that contains PIDD, an
adaptor protein RAIDD (receptor-interacting protein-associated
ICH-1/CED-3 homologous protein with a death domain), and
caspase-2 (Tinel and Tschopp, 2004). The death domain (DD)
of PIDD is essential for caspase-2 activation, and overexpres-
sion of PIDD results in spontaneous activation of caspase-2
and sensitization of the cells to genotoxic stress-induced
apoptosis (Tinel and Tschopp, 2004). The DD in the oligomeric
PIDDosome core complex displays eight unique asymmetric
interfaces, suggesting that the DD might engage multiple inter-
actions with other proteins similar to the core structure of apop-
tosome (Acehan et al., 2002; Park et al., 2007).
Interestingly, unlike other caspases, caspase-2 constitutively
localizes to the cell nucleus in addition to being present in other
cellular compartments (Colussi et al., 1998; Mancini et al., 2000;
Zhivotovsky et al., 1999). The prodomain of caspase-2 is
required for its nuclear localization (Baliga et al., 2003; Colussi
et al., 1998), and nuclear caspase-2 is rapidly cleaved in cells
upon DNA damage (Zhivotovsky et al., 1999). However, it
remains a mystery why caspase-2 is localized inside the cell
nucleus and whether the nuclear caspase-2 contributes to
apoptosis or other processes of the DNA damage response.
In this report, we identify a nuclear protein complex that
activates caspase-2 in the cell nucleus. It contains PIDD, cas-
pase-2, and the catalytic subunit of DNA-PK (DNA-PKcs) but
not RAIDD. In response to g-radiation, caspase-2 is phosphory-
lated at S122 within its prodomain by DNA-PKcs, whose kinase
activity is promoted by PIDD, leading to caspase-2 cleavage and
activation. Characterization of this complex reveals unexpected
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and 2), whereas no direct binding was detected between PIDD
and caspase-2 unless DNA-PKcs was added (lanes 3 and 4).
Thus, DNA-PKcs is required for the three to associate. Moreover,
the DD of PIDD could bind to the N-terminal 403-amino-acid
fragment of DNA-PKcs (Figure 1G,middle) that contains a helical
HEAT repeat, a protein-protein interaction motif (Figure 1A)
(Brewerton et al., 2004; Groves and Barford, 1999). The
prodomain of caspase-2 was found to predominantly bind the
C-terminal catalytic PI-3 kinase (PI3K) domain of DNA-PKcs
(Figure 1G, bottom). Thus, DNA-PKcs serves as a central
adaptor bridging the three proteins together (Figure 1H).
The size of this preformed complex analyzed by gel filtration
chromatography corresponds to a molecular mass of close to
2 million Daltons (Figure S4A). Ionizing radiation (IR) treatment
neither changed the fraction positions of these three proteins
nor triggered a significant increase in the amounts of the pre-
formed complex (Figure S4B). However, IR did trigger a shift of
Ku70/Ku80 heterodimer to the preformed complex fractions
(Figure S4B). This cofractionation suggests that DNA-PKcs
kinase activity in this complex could be enhanced by the
coeluted Ku70/80 after IR treatment because the Ku heterodimer
is a regulatory subunit of DNA-dependent protein kinase (DNA-
PK) and promotes the recruitment of DNA-PKcs to DNA ends
from which the kinase is activated (Gottlieb and Jackson,
1993). Neither RAIDD nor receptor interacting protein kinase-1
(RIP1) was cofractionated with this complex irrespective of IR
treatment (Figure S4), the latter being a component of the
PIDD-RIP1-NEMO complex responsible for DNA damage-
induced activation of nuclear factor kB (Janssens et al., 2005).
Considering the similarity and difference of this complex with
the previously reported RAIDD-containing PIDDosome (Tinel
and Tschopp, 2004), we named this complex the DNA-PKcs-
PIDDosome, and the other the RAIDD-PIDDosome.
Damage to DNA Increases Active Caspase-2 Bound
to the DNA-PKcs-PIDDosome
DNA-PKcs, PIDD, and caspase-2 are known players in various
aspects of cellular processes of DNA damage. To gain insight
into the function of the DNA-PKcs-PIDDosome, we treated
HeLa cells with IR, labeled these cells with b-VAD-fmk, and iso-
lated the DNA-PKcs-PIDDosome with streptavidin-sepharose
beadpull down.Damage toDNA resulted inasignificant activation
and increase in the binding of active caspase-2 (full length, p37,
and p20 fragments) to the DNA-PKcs-PIDDosome (Figure 2A,
lane 4), suggesting that the DNA-PKcs-PIDDosome functions as
aplatform for nuclear caspase-2activation.However, a significant
increase in the formation of DNA-PKcs-PIDDosome after IRmight
not be amajormechanism for caspase-2 activation, because only
amild increase in the levels of PIDD andDNA-PKcswasobserved
(Figure 2A, lane 4). Consistent with the idea that RAIDD is not part
of the DNA-PKcs-PIDDosome, RAIDD was not detected in the
complex even after IR treatment (Figure 2A).
Identification of the Site S122 in Caspase-2 as a DNA
Damage-Induced Phosphorylation Site by TandemMass
Spectrometry
DNA-PKcs is a nuclear serine/threonine protein kinase. It is acti-
vated by DNAdamage andmodulates the activities ofmany of its
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and the repair of DNA double-strand breaks (DSBs) mediated
by the NHEJ pathway. Our results underscore the complexity
and additional regulations of the mammalian G2/M cell cycle
checkpoint and the NHEJ pathway.
RESULTS
Identification of DNA-PKcs as a Major PIDD-Interacting
Protein in the Cell Nucleus
We took an unbiased approach to search for PIDD-interacting
proteins by immunoprecipitation (IP) from cell nuclear extracts
prepared from an HEK293 cell line stably expressing a FLAG-
tagged PIDD. The PIDD-associated proteins were identified by
Multidimensional Protein Identification Technology (MudPIT). In
addition toPIDD itself, anothermajor protein in thePIDD immuno-
complex is the catalytic subunit of the DNA-dependent protein
kinase, DNA-PKcs (Figure 1A), a nuclear serine/threonine protein
kinase that mainly functions in the NHEJ pathway to repair DNA
DSBs (Burma and Chen, 2004). The detected 20% peptide
coverage of DNA-PKcs (Figure 1B) is high considering the large
mass of DNA-PKcs (470 kDa, 4128 amino acids).We confirmed
this interaction by reciprocal IP (Figures 1C, 1D, and S1A avail-
able online), and characterized this interaction to be independent
of DNA by ethidium bromide or micrococcal nuclease treatment
of the nuclear extracts (Figure S1B). Surprisingly, we did not
detect the presence of RAIDD in this immunocomplex either by
immunoblotting or MudPIT despite its presence in the nuclear
extracts (Figures 1C, 1D, and S1A), suggesting that RAIDD is
not associated with this fraction of nuclear PIDD.
PIDD, DNA-PKcs, and Caspase-2 Form a Nuclear
DNA-PKcs-PIDDosome Complex
Because PIDD is involved in caspase-2 activation (Tinel and
Tschopp, 2004), the interaction between PIDD and DNA-PKcs
prompted us to examine whether PIDD and DNA-PKcs were
also associated with caspase-2 in the cell nucleus. Taking
advantage of the fact that there is an active pool of caspase-2
in unstimulated cells (Tinel and Tschopp, 2004) that can
bind to the cell-permeable, biotinylated pan-caspase inhibitor
b-VAD-fmk in living cells (Read et al., 2002; Tinel and Tschopp,
2004; Tu et al., 2006), we incubated HeLa cells with b-VAD-fmk
and used streptavidin-sepharose beads to pull down b-VAD-fmk
from the cell nuclear extracts. A fraction of the endogenous
active nuclear caspase-2, and importantly fractions of DNA-
PKcs and PIDD, were pulled down in a b-VAD-fmk dose-depen-
dent manner (Figure 1E). The caspase-2 dependency of this pull
down was confirmed because the association of DNA-PKcs and
PIDD with caspase-2 was not detected in caspase-2-deficient
mouse embryonic fibroblast (MEF) cells (Figure S2). These
results demonstrate that without any stimulation, these three
proteins already interact in viable cell nuclei. This pre-existing
interaction is not restricted to HeLa or MEF cells and is also
present in HEK293 cells (Figure S3). Again, RAIDD is not present
in the b-VAD-fmk nuclear pull-down complex (Figure 1E).
Furthermore, these three purified proteins could directly
interact to form a trimolecular complex in vitro (Figure 1F).
DNA-PKcs directly bound to PIDD or caspase-2 (lanes 1
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Figure 1. PIDD, DNA-PKcs, and Caspase-2 Form a Nuclear DNA-PKcs-PIDDosome
(A) Domain organizations in human caspase-2 (C2), PIDD, and DNA-PKcs (PKcs). Arrowheads point to the three cleavage sites in caspase-2. LS indicates the
large subunit (p20), and SS the small subunit (p10). Domains in PIDD shown are leucine-rich repeat (LRR), ZU5 (ZO-1 and Unc5-like netrin receptors), and the
death domain (DD). Domains in DNA-PKcs shown are a HEAT (huntingtin-elongation-A-subunit-TOR) repeat, clusters of phosphorylation sites (P and stars), and
the catalytic PI-3 kinase domain (PI3K).
(B) DNA-PKcs is amajor PIDD-interacting protein in cell nucleus identified bymass spectrometry. PIDD-interacting proteinswere purified by immunoprecipitation
(IP) from HEK293 cells stably expressing FLAG-PIDD. Shown are spectral counts (SpC) and sequence coverage (SeqCov) for PIDD and DNA-PKcs.
(C) Association of DNA-PKcs and PIDD. Nuclear extracts (50 mg) were prepared from the HEK293 cells described in (B) and HEK293 cells expressing an empty
vector (Vector). PIDD was immunoprecipitated by anti-FLAG-M2 antibody and the IP samples were analyzed by immunoblotting (IB) against FLAG, DNA-PKcs,
and RAIDD.
(D) Identical nuclear extracts to (C) were immunoprecipitated by anti-DNA-PKcs antibody.
(E) In vivo association of endogenous caspase-2, DNA-PKcs, and PIDD in live HeLa cell nuclei. HeLa cells (23 107) were labeled with cell-permeable biotinylated-
VAD-fmk (b-VAD-fmk) or DMSO (0) and the b-VAD-fmk-bound protein complex was isolated by streptavidin bead-pull down and immunoblotted with the
indicated antibodies. Caspase-2 was full length (FL) detected by anti-caspase-2 antibody.
(F) In vitro direct binding of the three proteins. Recombinant PIDD and caspase-2 (purified from bacteria) and DNA-PKcs (purified from HeLa cell nuclei) were
incubated (each at 20 nM) either in pairs or all together. Protein bindings were examined by IP followed by IB.
(G) Mapping the interaction domains. GST-fused fragments of DNA-PKcs (top, stained by Coomassie blue R-250) were incubated either with recombinant DD of
PIDD or with the FLAG-tagged prodomain of caspase-2 followed by glutathione agarose pull down. The protein interactions were detected by IB using anti-PIDD
and anti-FLAG antibodies. Numbers on the top indicate the DNA-PKcs residues included in each GST-fused truncated DNA-PKcs protein.
(H) Schematic of interactions. DNA-PKcs is the central component to bridge PIDD and caspase-2 in the complex. Pro indicates the prodomain of caspase-2.
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pase-2 function because it is conserved in humans, mice, and
rats, and a similar S-hydrophobic consensus SF motif is also
found in Xenopus caspase-2 (Figure 2D). Although the SQ and
TQ motifs are the major DNA-PK phosphorylation sites (Collis
et al., 2005; Lees-Miller, 1996), no phosphorylation at the S65Q
motif in caspase-2 was detected by tandemmass spectrometry.
DNA-PKcs Mediates the Phosphorylation of Nuclear
Caspase-2 at S122 In Vivo
This S122 phosphorylation appears to be important for caspase-
2 activation, because prevention of this phosphorylation in the
S122A MEF line resulted in a blockage of IR-induced caspase-
2 activation, as reflected by the lack of active p20 fragment
(Figure 3A) shown earlier to be active and bound to b-VAD-fmk
(Figure 2A).protein substrates by phosphorylation (Smith and Jackson,
1999). We examined if nuclear caspase-2 is phosphorylated
and identified the site serine 122 (S122) to be phosphorylated
after DNA damage induction by IR or etoposide treatment using
MudPIT combined with spectral count analysis (Figures 2B and
2C). This phosphorylation in this nuclear sample was confirmed
by immunoblotting with a caspase-2 anti-phospho-S122
(pS122) antibody (Figure S5).
The site S122 in caspase-2 is followed by a leucine residue,
which conforms to the ‘‘S-hydrophobic’’ consensus DNA-PK
phosphorylation sites. Similar phosphorylation sites have been
identified in the S6Y motif in Ku70 (Chan et al., 1999), the
S2624L autophosphorylation site in DNA-PKcs itself (Ding
et al., 2003), and the S127L motif in c-Fos (Anderson and
Lees-Miller, 1992). This S122L motif could be important for cas-
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Figure 2. DNA Damage Induces Caspase-2 Serine 122 Phosphorylation
(A) DNA damage activates caspase-2 bound to the DNA-PKcs-PIDDosome. HeLa cells were exposed to 80Gy IR. Eight hours after IR, cells (23 107) were labeled
with b-VAD-fmk (4 mM) for 1 hr, nuclear extracts were subjected to streptavidin bead pull down, and immunoprecipitates were analyzed by IB against the mole-
cules indicated.
(B) Quantification of phosphopeptides containing phosphorylated S122 (pS122). HEK293 cells stably expressing FLAG-tagged caspase-2 (C303A) were left
untreated (), exposed to 80 Gy IR (+IR), or treated with 100 mM etoposide (+ETOP) for 2 hr. Caspase-2 was FLAG-affinity-purified, and phosphorylation of cas-
pase-2 was analyzed byMudPIT combined with spectral count analysis. Each bar represents the mean and standard deviation (mean ± SD) of three independent
experiments (n = 3).
(C) Annotation of a representative tandem mass spectrum matched to L.SGLQHVLPPLSCDYDLpSLPFPV.C from elastase-digested caspase-2. The doubly
charged precursor ion with a protonated mass of 2535.71 Da is marked by the green triangle under them/z-axis, whereas the phosphate neutral loss peak is de-
notedwith ‘‘Phs.’’ Fragment ions bearing phosphorylated serine 122 (circled) arematched in bothb and y ion series, which are labeled in red andblue, respectively.
(D) Sequence alignment of humancaspase-2 (residues 116–153)withmouse, rat, andXenopus caspase-2 showing the conservedDNA-PKcsphosphorylation site
S122 (arrow). ThePKCK2phosphorylation siteS157 in humancaspase-2 (solid arrowhead) and theCaMKII phosphorylation siteS135 inXenopuscaspase-2 (open
arrowhead) are also shown.
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Figure 3. DNA-PKcs Mediates S122 Phosphorylation and Activation of Caspase-2 In Vivo, which Is Facilitated by PIDD
(A) Phosphorylation sitemutation attenuated IR-induced p20 cleavage of caspase-2. The immortalized caspase-2-deficientMEFs stably expressingWT or S122A
mutant caspase-2 were irradiated (10 Gy for 2 hr) and nuclear extracts were analyzed by IB.
(B) DNA-PKcs-specific inhibitor blocks caspase-2 phosphorylation at S122 and reduces the p20 cleavage. HeLa cells were incubated for 1 hr with 1.3 mM or
10 mM inhibitor NU7026 before treatment with 80 Gy. After an additional 24 hr, cells were harvested. Nuclear caspase-2 was detected by IB with caspase-2
antibody and the phosphorylated caspase-2 by an antibody specific for phospho-serine 122 in nuclear extracts.
(C) Caspase-2 phosphorylation at the S122 site is abolished in DNA-PKcs-deficient cells. Human gliomaM059J (DNA-PKcs-deficient) and isogeneic DNA-PKcs-
proficient ML-L24 (with exogenous [exo] wild-type [WT] DNA-PKcs expressed back) cells were exposed to 80 Gy IR. After an additional culture for 24 hr, cells
were harvested and nuclear extracts were analyzed by IB.
(D) DNA damage induces PIDD accumulation in the cell nucleus. HCT116 p53+/+ and HCT116 p53/ cells were untreated or exposed to 80 Gy IR, and harvested
at 0, 24, or 36 hr after IR. Cytosolic and nuclear fractions were analyzed by IB.
(E) PIDD overexpression facilitates nuclear caspase-2 phosphorylation and processing. HEK293T cells were transfected with increasing amounts of pcDNA-
FLAG-PIDD for 24 hr. Nuclear extracts were analyzed by IB. The p20 cleavage product of caspase-2 was better illustrated with longer exposure (bottom).
(F) PIDD requires DNA-PKcs to enhance phosphorylation at S122 and nuclear caspase-2 cleavage. pcDNA-FLAG-PIDD was transfected into isogenic ML-L24
and M059J cells for 24 hr. Nuclear extracts were analyzed by IB.
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side treatment, which was demonstrated by anti-pS122 immu-
noblotting (Figures 3B and S5). Furthermore, DNA-PKcs is
amajor protein kinase in the cell nucleus thatmediates this phos-
phorylation, because this phosphorylation was abolished by the
inhibitor NU7026, which is highly selective for DNA-PKcs512 Cell 136, 508–520, February 6, 2009 ª2009 Elsevier Inc.(Veuger et al., 2003) (Figure 3B). Consistently, both this phos-
phorylation and caspase-2 cleavage into p20 fragment were
abolished in DNA-PKcs-deficient M059J cells (Figure 3C), and
in DNA-PKcs-deficient and Ku80-deficient MEFs (Figure S6).
The cells analyzed in Figures 3A and 3C were not undergoing
apoptosis despite the activation of caspase-2 (Figure S7).
assay when DNA-PK was activated by DNA (Figures 4A and
1A). This phosphorylation indeed occurs at the S122 site
because the S122A mutant caspase-2 failed to be phosphory-
lated (Figure 4B, lane 5 versus 1). Moreover, PIDD enhances
the phosphorylation of caspase-2 in a S122-dependent manner
(Figure 4B).
The direct phosphorylation of caspase-2 at the S122 site by
DNA-PKcs was reproduced in ‘‘cold’’ in vitro kinase assays by
anti-pS122 immunoblotting (Figure 4C). Using this assay, we
found that PIDD acts as a positive regulator for DNA-PK kinase
activity leading to caspase-2 phosphorylation and cleavage,
because PIDD significantly promoted the autophosphorylation
of DNA-PKcs at the S2056 site, which is an indicator of DNA-
PKcs kinase activity (Chen et al., 2005).
Caspase-2 Phosphorylation and Processing and PIDD
Accumulation in the Cell Nucleus Occur before Cell
Death
We showed earlier in several experiments that S122 phosphor-
ylation and caspase-2 cleavage had already occurred yet the
cells were not undergoing apoptosis (Figures S7 and S10). ToPIDD Overexpression Facilitates the DNA-PKcs-
Mediated Phosphorylation of Nuclear Caspase-2
at the S122 Site In Vivo
In addition to thefinding thatPIDDshuttlesbetweencytoplasmand
nucleus (Janssens et al., 2005), we observed a nuclear accumula-
tion of PIDD upon IR-induced DNA damage in HCT116 cells
(Figure 3D), as well as in HEK 239T and U2OS cells (Figure S8). In
contrast to the p53-dependent p21 accumulation, this PIDD accu-
mulation isnotcompletelyp53dependentbecause it alsooccurred
in HCT116 p53/ cells, albeit to a lesser extent (Figure 3D).
One of the functions of this PIDD nuclear accumulation,
resembled by the ectopic expression of PIDD, is to significantly
enhance the S122 phosphorylation and the p20 cleavage
product in the cell nucleus (Figure 3E) in a DNA-PKcs activity-
dependentmanner (Figures 3F andS9). Again, the activated cas-
pase-2 in these cells did not result in apoptosis (Figure S10).
DNA-PKcsPhosphorylatesCaspase-2at theS122Site,and
PIDD Enhances the Kinase Activity of DNA-PKcs In Vitro
A significant incorporation of g-[32P]-ATP into caspase-2 (p37,
containing the S122 site) was observed in an in vitro kinase
RE
TFigure 4. DNA-PK Directly Phosphorylates Caspase-2 In Vitro and PIDD Promotes the Kinase Activity of DNA-PKcs
(A) DNA-PK directly phosphorylates caspase-2 in vitro. A standard in vitro DNA-PK protein kinase assay was performed with purified recombinant human WT
caspase-2 in the presence or absence of sonicated salmon sperm DNA. The reaction products were resolved on SDS-PAGE and PhosphorImager analysis
showed g-[32P]-ATP incorporation into caspase-2, DNA-PKcs, and Ku70/80.
(B) PIDD enhances DNA-PKcs-dependent caspase-2 phosphorylation at the S122 site in vitro. The same in vitro DNA-PKcs reactions as in (A) were performed
with purified recombinant human caspase-2 mutated at catalytic site (C303A) or double-mutated at both catalytic and phosphorylation sites (C303A/S122A) with
purified recombinant PIDD added in some reactions, and the products were analyzed by PhosphorImager.
(C) PIDD activates DNA-PK kinase activity. DNA-PK kinase assays (cold, without g-[32P]-ATP) were performed in the presence of 10 mM ATP, and the reaction
products were analyzed by IB.
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Figure 5. Caspase-2 Contributes to a G2/M Checkpoint before Cell Death
(A) Time course of IR-induced HeLa cell death. Cells were irradiated with 80 Gy IR and dead cells were scored by trypan blue inclusion. Each bar represents the
mean ± SD of three independent experiments (n = 3).
(B) Nuclear extracts of HeLa cells treated identically as in (A) were analyzed by IB.
(C) Phosphorylation at S122 site is important for caspase-2 activation. Four isogenic caspase-2 cell lines were generated in immortalized caspase-2-deficient
MEFs by stably expressing either an empty vector [C2 (/) + Vector], wild-type [C2 (/) + WT], phosphorylation site mutant [C2 (/) + S122A], or catalytic
site mutant [C2 (/) + C303A] caspase-2. These cells were exposed to 4 Gy IR and cultured for additional 2 or 6 hr. Nuclear extracts were analyzed by IB.
(D) Apoptotic response in the four isogenic caspase-2 cell lines treated identically as in (C). Apoptotic cells were scored as Annexin-V-positive and PI (Propidium
Iodide)-negative. Staurosporine (STS) treatments served as a control. Each bar represents the mean ± SD of three independent experiments (n = 3).
(E) Caspase-2 impacts G2/M checkpoint. The four isogenic caspase-2 MEF lines treated with IR (4Gy and 3Gy) were stained for mitotic cells with anti-phospho-
S10-Histone H3 (p-H3) antibody and analyzed by flow cytometry.
(F) Influence of ATM kinase inhibitor on caspase-2 G2/M checkpoint. The isogenicWT and caspase-2-deficient MEF lines were incubated with 10 mMATM kinase
inhibitor for 1 hr before 4 Gy IR treatment and mitotic percentages were analyzed.
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tion relative to the onset of apoptosis, HeLa cells were irradiated
with IR (80 Gy) to induce cell death. It is surprising that, in the
cell nucleus, IR-induced S122 phosphorylation and increase in
the p20 fragment of caspase-2, as well as IR-induced PIDD
accumulation, had already occurred as early as 2–4 hr after irra-
diation, a much earlier event than the onset of IR-induced cell
death (Figures 5A and 5B). These observations are not just
limited to HeLa cells because similar results were also observed514 Cell 136, 508–520, February 6, 2009 ª2009 Elsevier Inc.in HEK293T and MJ-L24 cells (Figures S11 and S12). Surpris-
ingly, none of the three proteins impacts apoptosis induced
by g-radiation (80 Gy) over a period of up to 96 hr, and the
apoptotic percentage remained unchanged irrespective of
deficiency in each gene or DNA-PKcs-inhibitor treatment
(Figure S13) (for PIDD-knockout MEFs; C.M., F.B., and A.V.,
unpublished data). These observations indicate that DNA-
PKcs, PIDD, and caspase-2 might have a role in the cell nucleus
before apoptosis.
Caspase-2 Impacts G2/M Checkpoint in Response
to Low-Dose g-Radiation
Besides triggering apoptosis, DNA damage also induces an
evolutionarily conserved DNA damage response to activate
cell cycle checkpoints to arrest cell cycle progression and allow
for DNA repair so as to preserve genomic integrity (Kastan and
Bartek, 2004).
We looked for caspase-2 involvement in the G2/M DNA
damage checkpoint in human osteosarcoma U2OS cells, a cell
line widely used in G2/M checkpoint studies. Mitotic cells were
labeled with an anti-phospho-histone H3 antibody (Wang et al.,
2002; Xu et al., 2001). Knocking down caspase-2 in U2OS cells
with small-interfering RNA (siRNA) resulted in a higher
percentage of mitotic cells (i.e., a defect in G2/M checkpoint)
compared with control cells after 4 Gy IR treatment in the
absence of apoptosis induction (Figure S14). These results
suggest that caspase-2 impacts a G2/M DNA damage check-
point before apoptosis.
We further investigated the effect of caspase-2 on the G2/M
checkpoint in four immortalized and isogenic caspase-2-defi-
cient MEF lines, each reconstituted with an empty vector, wild-
type (WT), S122A, or C303A mutant caspase-2 (Figure 5C). We
first examined the phosphorylation and activation of caspase-2
in these cell lines. Consistently, in the absence of apoptosis
induction (Figure 5D), the same dose of irradiation (4 Gy) readily
induced phosphorylation at the S122 site and the p20 cleavage
of caspase-2 in WT cells at 2 hr and, to a greater extent, both
events were detected at 6 hr (Figure 5C, lanes 4–6). Furthermore,
the specificity of this caspase-2 phosphorylation event was
verified in the S122A cell lines (Figure 5C, lanes 7–9), and this
phosphorylation is independent of catalytic activity (Figure 5C,
lanes 10–12). Moreover, the p20 fragment cleavage of cas-
pase-2 was dependent on both S122 phosphorylation and cata-
lytic activity (Figure 5C, lanes 7–12). These cells, however, are
not intrinsically resistant to apoptosis because they all readily
underwent apoptosis when treated with the potent apoptotic
inducer staurosporine (Figure 5D).
Examination of the integrity of the G2/M checkpoint in these
cell lines indicates that there exists an IR-induced caspase-2-
dependent G2/M checkpoint in mammalian cells to delay the
progression of cells from G2 into M phase, which occurs around
2 hr and becomes stronger 6 hr after DNA damage induction
(Figure 5E). Specifically, unlike a normal G2 arrest induced by
4 Gy IR in MEFs expressing WT caspase-2, the caspase-2-defi-
cient MEFs exhibited a higher percentage of mitotic cells at 2 hr
(0.14%), and a greater loss of this checkpoint appeared at 6 hr
(0.88%, Figure 5E, left). An alternative evaluation of this partial
loss of checkpoint by the percentage of arrest at 6 hr (0.88%)
normalized to that observed in untreated cells (2.32%) indicated
38% of the mitotic cells failed to arrest in G2 phase and entered
mitosis. Such a greater checkpoint effect at 6 hr correlated with
the observed stronger S122 phosphorylation and caspase-2
activation at the same time point (Figure 5C, lane 6). In addition,
a lower dose of 3Gy triggered an even greater defect in theG2/M
checkpoint at 6 hr, with a significant80% of mitotic cells failing
to arrest in G2 phase (Figure 5E, right). Furthermore, cells ex-
pressing S122A or C303A mutant caspase-2 displayed a partial
loss of the G2/M checkpoint at both doses, and a greater loss
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nuclear caspase-2 at S122 and caspase-2 catalytic activity
both contribute to IR-induced G2/M cell cycle checkpoint.
The Caspase-2-Dependent G2/M DNA Damage
Checkpoint Follows the G2/M Checkpoint Regulated
by ATM
A defect in ataxia telangiectasia mutant (ATM) activity in ataxia
telangiectasia cells results in a defective G2/M checkpoint at
early time usually within 1–2 hr after DNA DSB induction (Xu
et al., 2002). We compared the time window between the cas-
pase-2-dependent and ATM-regulated G2/M checkpoints in
WTMEFs (C2 [/] reconstituted withWT caspase-2). As shown
in Figure 5F, inhibition of ATM in WT cells (lower left) significantly
reduced IR-induced G2 arrest at 2 hr (0.62%), and this effect had
weakened at 6 hr (0.27%), consistent with the established notion
that the ATM-dependent G2/M checkpoint occurs ‘‘early’’ after
DNA damage induction and is transient (Xu et al., 2002). In
addition, this ATM-dependent G2/M checkpoint does not
seem to depend on caspase-2 because inhibition of ATM in cas-
pase-2-deficient cells still resulted in a significant loss of G2/M
checkpoint 2 hr after IR (1.56%, lower right). In a striking
contrast, a temporally opposite G2 arrest was observed in cas-
pase-2-deficient cells (upper right), with a stronger reduction in
G2 arrest occurring at 6 hr (0.89%) and a milder reduction at
2 hr (0.20%), indicating that the caspase-2-dependent G2/M
checkpoint is temporally distinct from the ATM-dependent
checkpoint, with its effect appearing stronger ‘‘later’’ than the
rapid and early ATM checkpoint. Furthermore, caspase-2 is
important for sustaining the G2/M checkpoint because 90% of
the initial checkpoint activity occurring at 2 hr [(2.22  0.20)/
2.22] still remained in the absence of caspase-2, but that check-
point could not be sustained at 6 hr (upper right). Moreover, ATM
also has a partial effect on this caspase-2 checkpoint because
inhibition of ATM in caspase-2-deficient cells (lower right)
rescued a portion of that checkpoint loss, as shown by the
reduction in mitotic cells from 40% (0.89/2.22) to 28% (0.91/
3.29). This ATM effect could possibly be through ATM regulation
of DNA-PKcs phosphorylation, which has been reported to be
required for a full activation of DNA-PKcs (Chen et al., 2007).
DNA-PKcs Impacts the Caspase-2 G2/M DNA Damage
Checkpoint
ATM is a major G2/M checkpoint kinase in response to DSB
induction. In contrast, not much evidence has been reported
for a role of DNA-PKcs in G2/M arrest. The observed require-
ment of DNA-PKcs-mediated caspase-2 phosphorylation for
a G2 arrest argues that DNA-PKcs also has an impact on
the G2/M checkpoint. We indeed observed such an influence
of endogenous DNA-PKcs after the ATM checkpoint, although
the influence was not as strong as ATM. DNA-PKcs-deficient
cells showed a mild but clear loss of the G2/M arrest, which
also occurred more apparently at 6 hr (0.29%) than at 2 hr
(0.17%, Figure 6A), consistent with the kinetics of caspase-2-de-
pendnet checkpoint (Figure 5). Importantly, unlike the caspase-
2-independent ATM checkpoint (Figure 5F), the DNA-PKcs-
involved G2/M checkpoint depends on caspase-2 because
inhibition of DNA-PKcs only affected the G2/M checkpoint in
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Figure 6. DNA-PKcs and PIDD Affect G2/M DNA Damage Checkpoint
(A) DNA-PKcs contributes to a G2/M checkpoint. Immortalized WT and DNA-PKcs knockout MEF lines were irradiated with 4 Gy, cultured for 2 and 6 hr, and
mitotic percentages were analyzed.
(B) DNA-PKcs kinase inhibitor influences the caspase-2 G2/M checkpoint. Isogenic WT and caspase-2-deficient MEF lines were incubated with 10 mM DNA-
PKcs inhibitor for 1 hr, irradiated with 4 Gy of IR, and mitotic percentages were analyzed at 2 and 6 hr post IR.
(C) Endogenous PIDD contributes to a G2/M checkpoint. Isogenic WT and PIDD knockout MEF lines were treated and analyzed the same as in A.
(D) Endogenous PIDD is required for a full activation of nuclear caspase-2. Nuclear extracts from PIDD cell lines treated identically as in C were analyzed by IB.
(E) PIDD-overexpression induces a stronger activation of a G2/M checkpoint. HeLa cells stably expressing an empty vector or FLAG-tagged PIDD (PIDD-stable)
were exposed to 4 Gy IR, cultured for 1 and 2 hr, and analyzed for mitotic percentages.
(F) Requirement of caspase-2 for PIDD to activate a G2/M checkpoint. Caspase-2-deficient MEFs [C2 (/)] stably expressing an empty vector (Vector-stable) or
FLAG-tagged PIDD (PIDD-stable) were exposed to 4 Gy IR, cultured for additional 2 or 6 hr, and analyzed for mitotic percentages.
RE
TR
AC
TE
Dcaspase-2 WT cells (Figure 6B, lower), suggesting that the
influence of DNA-PKcs on the G2/M checkpoint is mediated by
caspase-2, likely owing to its phosphorylation of caspase-2.
PIDD Affects a G2/M DNA Damage Checkpoint Partially
through Caspase-2
Endogenous PIDD also has significant influence on the G2/M
checkpoint and shares a similar temporal trend to DNA-PKcs
and caspase-2 in that a greater effect occurred at 6 hr than at
2 hr (Figure 6C). The significant decrease in both IR-induced
phosphorylation at the S122 site and activation of caspase-2 in
PIDD deficient cells provide biochemical support for PIDD to516 Cell 136, 508–520, February 6, 2009 ª2009 Elsevier Inc.influence this caspase-2 checkpoint (Figure 6D). It is important
to note that unlike the abolished S122 phosphorylation and cas-
pase-2 activation in DNA-PKcs-inactive Ku80-deficient cells
(Figure S6), both events in PIDD-deficient cells were still occur-
ring, though they were significantly attenuated (Figure 6D). This
finding argues that DNA-PKcs is still active in the absence of
endogenous PIDD, and that PIDD acts like a ‘‘modifier’’ to
facilitate (but is not indispensable for) DNA-PKcs kinase activity
regarding IR-induced phosphorylation at the S122 site and cas-
pase-2 activation. Furthermore, stable overexpression of PIDD
in HeLa cells strengthened the G2 arrest (Figures 6E and S15A).
Moreover, this PIDD G2/M checkpoint depends on caspase-2
at 2 hr after IR and becomes partially dependent of caspase-2 at
6 hr (Figures 6F and S15B), suggesting that PIDD may also work
with other molecules to impact the G2/M checkpoint.
The DNA-PKcs-PIDDosome Influences NHEJ
DNA NHEJ is believed to be a major pathway of DSB repair in
higher eukaryotes by rejoining DSBs without any requirement
for a homologous template (Burma and Chen, 2004; Collis
et al., 2005). Although six mammalian NHEJ factors, including
DNA-PKcs, had been identified, the latest identification of the
seventh factor, XLF/Cernunnos (Ahnesorg et al., 2006; Buck
et al., 2006), indicates a high level of complexity in the composi-
tion of this repair pathway, and suggests that additional factors
still exist to affect this pathway.
We analyzed the effect of PIDD and caspase-2 on NHEJ in
MEFs transfected with a pEGFP-N1 plasmid linearized with
the restriction enzyme BsrGI that cleaves the plasmid within
the GFP coding region (Wang et al., 2006). The rationale was
that the GFP gene would only be expressed after the plasmid
was rejoined as the circular form. Similar to DNA-PKcs-defi-
cient cells, PIDD-deficient and caspase-2-deficient cells
displayed a significant reduction in end-joining activity (Figures
7A–7C and S16A–S16C), suggesting an involvement of PIDD
and caspase-2 in NHEJ. Furthermore, this observation was
confirmed in an independent in vivo assay in which the lacZ
reading frame in the plasmid substrate was restored after
end-joining (Figure S17). The impact of PIDD and caspase-2
on NHEJ was further confirmed at the DNA level by DNA
sequencing across the religation junctions generated by BsrGI.
All three knockout cell lines displayed a reduction in accurate
junction and a greater extent of nucleotide deletion than their
WT counterparts (Figures 7E-G). Further investigation in cells
expressing the S122A and C303A mutant caspase-2 displayed
a significant reduction in NHEJ activity similar to that observed
in caspase-2-deficient cells (Figures 7D and S16D), demon-
strating a contribution of these two sites to caspase-2-medi-
ated NHEJ.
DISCUSSION
Based on our findings, we propose the existence of a preformed
DNA-PKcs-PIDDosome complex in the cell nucleus in the
absence of stimulation, and that upon DNA damage this
complex activates nuclear caspase-2 through a previously un-
described ‘‘phosphorylation for activation’’ mechanism. PIDD
accumulates in the cell nucleus, binds to the N-terminal HEAT
repeat-containing region of DNA-PKcs, and acts like a modifier
to facilitate DNA damage-induced activation of DNA-PKcs,
probably by changing the conformation of DNA-PKcs. DNA-
PKcs, in turn, phosphorylates caspase-2 at its S122 residue,
leading to caspase-2 activation and cleavage. As a result, cas-
pase-2 gains the ability to impact two major processes in
a cellular response to DNA damage: the G2/M checkpoint and
NHEJ (Figure 7H). The current study raises interesting issues
with respect to the complexity of the G2/M checkpoint and
NHEJ regulation mediated by a caspase that has long been
implicated in the execution of apoptosis.
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It has been reported that caspase-2 can be inhibited by phos-
phorylation. Phosphorylation of Xenopus caspase-2 at serine
135 (S135) within its prodomain, mediated by calcium/
calmodulin-dependent protein kinase II (CaMKII), inhibits cas-
pase-2 and suppresses apoptosis in oocytes. Removal of this
inhibitory phosphorylation by depleting cells of glucose activates
caspase-2 and results in apoptosis in oocytes (Nutt et al., 2005).
Human caspase-2 can also be inhibited by phosphorylation at
the serine 157 (S157) site within its prodomain mediated by the
protein kinase casein kinase 2 (PKCK2). Dephosphorylation at
this site, therefore, activates caspase-2 to prime human cancer
cell apoptosis induced by TNF-related apoptosis-inducing
ligand (Shin et al., 2005). In contrast to inhibitory phosphoryla-
tion, our study presents an example that phosphorylation
induces caspase-2 activation. Phosphorylation of the S122 site
mediated by DNA-PKcs may induce conformational change in
caspase-2, making the D152 cleavage site more accessible to
the catalytic center. Clearly, the detailed molecular mechanism
of this regulation remains to be determined. Nonetheless, in
contrast to the fact that the physiological substrates of DNA-
PK in NHEJ have remained largely unknown (Collis et al., 2005;
Lees-Miller, 1996), in this current study caspase-2 has been
identified as a physiological substrate of DNA-PKcs for a G2/M
cell cycle arrest and NHEJ.
Two Distinct Caspase-2-Activating PIDDosome
Complexes
There are apparent similarities anddifferencesbetween theDNA-
PKcs-PIDDosome and RAIDD-PIDDosome (Figure 7H). Both
PIDDosomes are high-molecular-weight complexes and share
the components PIDD and caspase-2. However, each PIDDo
some contains a distinct central adaptor protein DNA-PKcs and
RAIDD. The activated caspase-2 also has distinct functions.
Spatially, the DNA-PKcs-PIDDosome phosphorylates and acti-
vates caspase-2 in the cell nucleus, whereas the RAIDD-PIDDo
some most likely activates caspase-2 in the cytoplasm. Tempo-
rally, the DNA-PKcs-PIDDosome impacts a G2/M checkpoint
and DNA repair in the early phase of the DNA damage response
before apoptosis, whereas the RAIDD-PIDDosome promotes
apoptosis in a later phase than the checkpoint activation when
DNA damage is severe and irreparable and cells are doomed to
die. Furthermore, the mechanism of activation is also distinct.
Phosphorylation of caspase-2 mediated by DNA-PKcs activates
the largely already formed DNA-PKcs-PIDDosome. In contrast,
the RAIDD-PIDDosome does not have a kinase component.
Considering the notion that cells can undergo apoptosis when
DNA damage is irreparable, it would be interesting to examine if
the two PIDDosomes are functionally connected.
The potential roles of the pre-existing DNA-PKcs-PIDDosome
in the absence of any exogenous stimulation may be to sense
the presence of endogenous DNA damages and to slow down
the cell cycle progression to allow for DNA repair. It may also be
advantageous to thedenovoassemblyof thiscomplexafterexog-
enous DNA damage induction, thereby allowing a quicker and
more efficient activation of caspase-2 for an effective signaling
in G2/M checkpoint and DNA DSB repair via the NHEJ pathway.
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Figure 7. Three Components of DNA-PKcs-PIDDosome Play Roles in NHEJ In Vivo
(A) DNA-PKcs functions in vivo in DNA end-joining. In vivo plasmid-based end-joining assay using the pEGFP-N1 vector linearized by BsrGI as substrate was
performed in immortalized WT and DNA-PKcs knockout MEF cells. The end-joining activity was estimated as the ratio of the percentage of GFP-positive cells
containing recirculized plasmid DNA arising from repair to that of GFP-positive cells transfected with uncut circular plasmid DNA. Each bar represents themean ±
SD of three independent experiments (n = 3); *p < 0.05 (two-tailed Student’s t test).
(B) PIDD functions in vivo in DNA end-joining (assayed the same as in A).
(C) Caspase-2 functions in vivo in DNA end-joining (assayed as in A).
(D) Both S122 and C303 sites are required for caspase-2 end-joining activity. The same in vivo end-joining assay as in (A) was performed in the four isogenic
caspase-2 cell lines. The end-joining activity in C2 (/) + WT cells was arbitrarily set at 100%, which served as a reference, and the activities in three other
cell lines were normalized to that in C2 (/) + WT cells. Each bar represents the mean ± SD of three independent experiments (n = 3); *p < 0.05 (two-tailed
Student’s t test).
(E–G) The junction accuracy frequencies of in vivo DNA end-joining. The religation junctions ofBsrGI restriction site were sequenced. The DNA sequencing results
with the exact nucleotides of BsrGI restriction site (red letters) were shown at the top of each set of sequences. The number of times each sequence was rep-
resented in the data set was indicated in the column ‘‘Outcome Type’’ as ‘‘#’’; also shown in the same column was the nucleotide loss (empty space) from the
religation ends as ‘‘’’; the nucleotide addition (green letters) as ‘‘+’’; and the nucleotide loss and addition as ‘‘±’’.
(H) Working model for the roles of DNA-PKcs-PIDDosomes in DNA damage-induced cellular responses. In addition to the RAIDD-PIDDosome that is present
mainly in cytoplasm to activate caspase-2 for apoptosis, the DNA-PKcs-PIDDosome is preformed in the cell nucleus without any stimulation. DNA damage
(IR) induces nuclear caspase-2 phosphorylation at the serine 122 site within its prodomain, and this phosphorylation is mediated by DNA-PKcs, whose kinase
activity is facilitated by PIDD, leading to nuclear caspase-2 activation and cleavage. Both this phosphorylation and the catalytic activity of nuclear caspase-2
contribute to G2/M DNA damage checkpoint and NHEJ.
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time for repair. Furthermore, the molecular compositions and
mechanism of action of the two checkpoint components are
distinct. The early ATM checkpoint comprises ATM-Chk2-
Cdc25, and the checkpoint kinases ATM and Chk2Relations between Caspase-2-Dependent
and ATM-Dependent G2/M Checkpoints
The caspase-2 G2/M checkpoint is kinetically distinct from the
ATM G2/M checkpoint, with its role appearing prominently after
the rapid ATM checkpoint is mostly executed, providing amech-
phosphorylate and inhibit the Cdc25 family of phosphatases that
normally activate mitotic entry (Sancar et al., 2004). In contrast,
the later caspase-2 checkpoint consists of DNA-PKcs, PIDD,
and caspase-2. DNA-PKcs phosphorylates and activates cas-
pase-2, and the caspase-2 catalytic activity is required to fully
execute the G2/M checkpoint via certain targets yet to be iden-
tified. Moreover, the early ATM checkpoint does not seem to
require caspase-2, whereas the later caspase-2 checkpoint
seems to partially depend on ATM and might be subjected to
ATM regulation. This ATM effect could possibly be through
ATM regulation of DNA-PKcs phosphorylation, which has been
reported to be required for a full activation of DNA-PKcs (Chen
et al., 2007).
How Nuclear Caspase-2 Impacts the G2/M Checkpoint
and NHEJ
Our study has raised an important question as to what the down-
stream caspase-2 target(s) is/are for carrying out the G2/M
checkpoint and NHEJ. So far only a few protein substrates of
caspase-2, mostly in vitro, have been reported: caspase-2 itself,
Golgin-160, aII-spectrin, PKCd, and Bid (Gao et al., 2005;
Mancini et al., 2000; Rotter et al., 2004; Xue et al., 1996). Clearly,
their functional significance in caspase-2-dependent G2/M
checkpoint and NHEJ can be investigated in the future. Based
on the finding from the current study that the catalytic activity
of caspase-2 is involved in both the G2/M checkpoint and
NHEJ, we hypothesize that certain G2/M checkpoint regulator(s)
is/are cleavable by caspase-2, and that these candidate targets
could be positive or negative regulators of the two processes
because it remains unknown if caspase-2 cleavage induces
a loss of function or a gain of function of the substrate(s). This
current study provides insight into searching for these cas-
pase-2 substrates to address how nuclear caspase-2 is inte-
grated into the current G2/M checkpoint and NHEJ pathways.
EXPERIMENTAL PROCEDURES
Stable Cell Lines
Primary MEFs were immortalized by SV40 large T antigen. The main MEFs
used were WT and knockouts of DNA-PKcs, Ku80, PIDD, caspase-2, and
RAIDD. See Supplemental Data for complete cell line information.
Immunoprecipitation
Nuclear extracts were prepared as reported previously (Dignam et al., 1983).
Two milligrams of nuclear extract was precleared with protein G agarose
(Roche) and incubated with antibodies plus protein G agarose beads at 4C
overnight. The immunoprecipitates were washed four times and subjected
to SDS-PAGE and immunoblotted with specific antibodies.
Immunofluorescent Detection of Mitotic Cells
Cells fixed with 70% ethanol were permeabilized in 1 ml 0.25% Triton X-100 in
phosphate-buffered saline. Approximately 1 3 106 cells were stained with
10 mg/ml fluorescein-isothiocyanate-conjugated antibody against phosphory-
lated histone H3 Ser 10 (Upstate Biotechnology) for 1 hr at room temperature in
the dark, followed by propidium iodide (20 mg/ml) staining. Cellular fluores-
cence was monitored with a CyAn flow cytometer (Dako). Two-dimensional
dot plots were generated by FloJo 8.2 software.
In Vivo DNA End-Joining Assay
The plasmid-based DNA end-joining in vivo assay was performed as
described previously (Wang et al., 2006). The green florescent protein (GFP)
RE
TRvector (pEGFP-N1, Clontech), linearized using BsrGI to cut within the GFP
coding region, was utilized to measure DNA end-joining activity, and the reli-
gated junction accuracy was sequenced. See Supplemental Data for details.
SUPPLEMENTAL DATA
The Supplemental Data include 17 figures and can be found with this article
online at http://www.cell.com/supplemental/S0092-8674(08)01609-7.
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